Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
142M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
14.9M
-
Shares change
-
-204K
-
Total reported value, excl. options
-
$133M
-
Value change
-
-$7.91M
-
Put/Call ratio
-
0.52
-
Number of buys
-
34
-
Number of sells
-
-25
-
Price
-
$8.95
Significant Holders of Applied Therapeutics, Inc. - COMMON STOCK (APLT) as of Q4 2021
79 filings reported holding APLT - Applied Therapeutics, Inc. - COMMON STOCK as of Q4 2021.
Applied Therapeutics, Inc. - COMMON STOCK (APLT) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.9M shares
of 142M outstanding shares and own 10.52% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2.31M shares), FMR LLC (2.24M shares), BlackRock Inc. (1.3M shares), FRANKLIN RESOURCES INC (1.13M shares), Point72 Asset Management, L.P. (1.11M shares), Knoll Capital Management, LLC (1.03M shares), VANGUARD GROUP INC (851K shares), Rock Springs Capital Management LP (702K shares), EMERALD MUTUAL FUND ADVISERS TRUST (632K shares), and EMERALD ADVISERS, LLC (612K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.